Epoch Investment Partners, Inc. Biogen Inc. Transaction History

Epoch Investment Partners, Inc.

$21.8 Billion
Q1 2024

A detailed history of Epoch Investment Partners, Inc. transactions in Biogen Inc. stock. As of the latest transaction made, Epoch Investment Partners, Inc. holds 1,339 shares of BIIB stock, worth $310,406. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,339

Previous 277,224 99.52%

Holding current value

$310,406

Previous $71.7 Million 99.6%

% of portfolio

0.0%

Previous 0.33%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$212.02 - $267.71 $58.5 Million - $73.9 Million	-275,885 Reduced 99.52%	1,339 $288,000
Q4 2023 Feb 13, 2024	BUY	$222.59 - $267.94 $20.3 Million - $24.4 Million	91,178 Added 49.01%	277,224 $71.7 Million
Q3 2023 Nov 13, 2023	SELL	$253.3 - $285.89 $4.3 Million - $4.85 Million	-16,970 Reduced 8.36%	186,046 $47.8 Million
Q2 2023 Aug 11, 2023	SELL	$275.25 - $318.06 $1.97 Million - $2.28 Million	-7,160 Reduced 3.41%	203,016 $57.8 Million
Q1 2023 May 12, 2023	SELL	$256.56 - $292.34 $2.93 Million - $3.34 Million	-11,425 Reduced 5.16%	210,176 $58.4 Million

Q4 2022 Feb 13, 2023	BUY	$252.44 - $306.72 $1.97 Million - $2.39 Million	7,803 Added 3.65%	221,601 $61.4 Million
Q3 2022 Nov 14, 2022	SELL	$194.69 - $268.46 $1.13 Million - $1.56 Million	-5,809 Reduced 2.65%	213,798 $57.1 Million
Q2 2022 Aug 15, 2022	BUY	$187.54 - $223.02 $7.25 Million - $8.63 Million	38,681 Added 21.38%	219,607 $44.8 Million
Q1 2022 May 13, 2022	BUY	$193.77 - $244.14 $35.1 Million - $44.2 Million	180,926 New	180,926 $38.1 Million
Q1 2019 May 14, 2019	SELL	$216.71 - $338.96 $3.96 Million - $6.2 Million	-18,280 Closed	0 $0
Q4 2018 Feb 13, 2019	BUY	$278.5 - $352.75 $136,465 - $172,847	490 Added 2.75%	18,280 $5.5 Million
Q3 2018 Nov 13, 2018	SELL	$293.51 - $383.83 $1.92 Million - $2.51 Million	-6,550 Reduced 26.91%	17,790 $6.29 Million
Q2 2018 Aug 13, 2018	BUY	$257.52 - $306.91 $4.38 Million - $5.22 Million	17,007 Added 231.92%	24,340 $7.06 Million
Q1 2018 May 14, 2018	BUY	$260.13 - $367.91 $19,769 - $27,961	76 Added 1.05%	7,333 $2.01 Million
Q4 2017 Feb 13, 2018	BUY	$307.64 - $344.58 $29,225 - $32,735	95 Added 1.33%	7,257 $2.31 Million
Q3 2017 Nov 13, 2017	BUY	$281.15 - $329.69 $2.01 Million - $2.36 Million	7,162	7,162 $2.24 Million

Others Institutions Holding BIIB

# of Institutions

1,046

Shares Held

126M

Call Options Held

1.37M

Put Options Held

1.35M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $33.4B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Epoch Investment Partners, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Epoch Investment Partners, Inc. with notifications on news.

Account

Epoch Investment Partners, Inc. Biogen Inc. Transaction History